Trial Profile
Characteristics of multiple sclerosis patients treated with fampridine in a real-world setting
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2018
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 30 Oct 2018 New trial record
- 12 Oct 2018 Results (n=1159, data cut off: Apr 2018) presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis